Serotalin GmbH endeavours to make its website https://serotalin.de accessible in accordance with national legislation implementing Directive (EU) 2016/2102 of the European Parliament and of the Council.

This accessibility statement applies to the website https://serotalin.de

Status of compliance with the requirements

This website is partially compliant with BITV 2.0 in conjunction with EN 301 549 and the BFSG.

Non-accessible content

(a) Incompatibility with national law:

• Non-descriptive link texts (e.g. "click here")
• Missing alternative text for images
• Problems with keyboard controls in the checkout area
• Missing ARIA roles for interactive components

b) Disproportionate burden:

• A complete redesign of the ordering process is planned, but currently not economically feasible. Implementation is scheduled for Q4 2025.

c) Content not falling within the scope of application:

• PDF documents before June 28, 2025. We will provide accessible alternatives upon request.

Creation of this Accessibility Statement

This statement was prepared on June 5, 2025.
It is based on a self-assessment pursuant to Article 3(1)(a) of Implementing Decision (EU) 2018/1523.
The statement was last reviewed on June 5, 2025.

Feedback and contact information

You can report digital accessibility issues via:

• Email: support@serotalin.de

Responsible:
Serotalin GmbH

this represented by Managing Director Tobias Cvijic
Am Mühlberg 22
93077 Bad Abbach
Germany
Phone: +49(0)9405 5069910 (Support requests via email only)
Email: support@serotalin.de

Enforcement proceedings

If you do not receive a satisfactory answer, you can contact the following:

Arbitration Board BGG
c/o German Disability Council
Adenauerallee 127, 53113 Bonn
Phone: 030 18527-2805
Email: info@schlichtungsstelle-bgg.de
Website: https://www.schlichtungsstelle-bgg.de

Optional content

Serotalin GmbH aims to achieve WCAG 2.1 AA compliance by the end of 2025. Regular reviews and improvements are ongoing. Website published in 2021. Last content update: May 2025.